EXPERTS IN PEPTIDE DRUG DISCOVERY AND DEVELOPMENT
Discovery, Development & Partnerships
We are advancing next-generation peptide therapeutics through a focused, data-driven discovery engine, rooted in years of peptide drug discovery and strengthened by selected strategic partnerships.
Consult with Louise S. Dalbøge
Chief Science Officer
Choose the right, trustworthy discovery partner.
Collaboration with Gubra
Drug Discovery and Development
Combine deep peptide expertise with AI-driven discovery to rapidly deliver development candidates and advance successful programs.
R&D Pipeline
Explore our robust and growing pipeline of peptide pre-clinical and clinical programs.
streaMLine Platform
Synthesize and screen thousands of peptides, using machine-learning and advanced models to accelerate drug discovery.
Partnering
Partner with us to develop tomorrow’s novel peptide therapeutics.
balanced portfolio of internal & partnered programs
Gubra’s R&D Pipeline
Gubra’s R&D pipeline is driven by a strong focus on peptide drug discovery and development. We are advancing a growing portfolio of programs across key therapeutic areas, including metabolic, endocrine, and hematological disorders. Our deep expertise in peptides enables us to discover and develop innovative drug candidates, both through our proprietary initiatives and in close collaboration with strategic partners.
MACHINE LEARNING-ASSISTED ANALYSIS OF THOUSANDS OF PEPTIDES
StreaMLine
At Gubra, we continuously advance our knowledge and innovate our technology. Visit our resource library to explore the latest publications on streaMLine, our in-house machine-learning platform.
We believe the most meaningful innovations happen together
That’s why we are eager to collaborate with forward-thinking partners to co-create transformative therapeutic options, blending our expertise to drive science and value forward.
Related pages
For further information
Contact us
Gubra
Hørsholm Kongevej 11B
2970 Hørsholm
Denmark
+45 3152 2650